Status:

ACTIVE_NOT_RECRUITING

A Clinical Study of ONO-1110 in Patients With Fibromyalgia

Lead Sponsor:

Ono Pharmaceutical Co., Ltd.

Conditions:

Fibromyalgia

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

To Evaluate the Efficacy and Safety of ONO-1110 in Patients with Fibromyalgia

Eligibility Criteria

Inclusion Criteria:

  • Japanese (both sexes)
  • Outpatient
  • Patients who are considered capable of understanding the study procedures and completing the pain diary and questionnaires appropriately by the investigator (sub-investigator)
  • Patients who meet the American College of Rheumatology Fibromyalgia Criteria

Exclusion Criteria:

  • Patients with inflammatory arthritis, infectious arthritis, or autoimmune disease
  • Patients with pain other than FM that may affect assessments in this study
  • Patients with a past history of or concurrent neurologic diseases that may affect assessments in this study
  • Patients with a past history of or concurrent malignant tumor within 3 years
  • Patients who are pregnant, nursing, or possibly pregnant, or intending to become pregnant during the study period.

Key Trial Info

Start Date :

March 26 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2026

Estimated Enrollment :

160 Patients enrolled

Trial Details

Trial ID

NCT06752590

Start Date

March 26 2025

End Date

September 1 2026

Last Update

March 25 2026

Active Locations (30)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 8 (30 locations)

1

Aichi Medical University Hospital

Nagakute, Aichi-ken, Japan

2

Kimura Clinic

Nagoya, Aichi-ken, Japan

3

National Hospital Organization Shimoshizu National Hospital

Yotsukaidō, Chiba, Japan

4

Ai Sakura Clinic

Fukuoka, Fukuoka, Japan